New radiation device aims to cut breast cancer treatment time

NCT ID NCT03562273

Recruiting now Symptom relief Sponsor: University of Maryland, Baltimore Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a special radiation device called the GammaPod to give a single, precise dose of radiation to the area where breast cancer was removed. The goal is to see if this approach can shorten the overall treatment time by a few days and improve patients' quality of life. About 160 women who have had breast-conserving surgery will participate. Researchers will track side effects, tumor control, and use questionnaires to measure quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer female breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER FEMALE

Contacts and locations

Locations

Baltimore Washington Medical Center
RECRUITING

Glen Burnie, Maryland, 21061, United States
Central Maryland Oncology Center
RECRUITING

Columbia, Maryland, 21044, United States
UTSouthwestern
RECRUITING

Dallas, Texas, 75390, United States
Upper Chesapeake Health
RECRUITING

Bel Air, Maryland, 21014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.